RT @Aiims1742: Cost effectiveness of first line treatment for metastatic #PancreaticCancer USA: https://t.co/g47pJg3bBF (Threshold of $200…
Quality of life vs Cost-effectiveness vs Evidence-based treatment. Should patients really have to choose what’s most important to them? #FightingCancer #clinicaltrials https://t.co/3u9VPBWXH1
RT @Aiims1742: Cost effectiveness of first line treatment for metastatic #PancreaticCancer USA: https://t.co/g47pJg3bBF (Threshold of $200…
RT @Aiims1742: Cost effectiveness of first line treatment for metastatic #PancreaticCancer USA: https://t.co/g47pJg3bBF (Threshold of $200…
RT @Aiims1742: Cost effectiveness of first line treatment for metastatic #PancreaticCancer USA: https://t.co/g47pJg3bBF (Threshold of $200…
Cost effectiveness of first line treatment for metastatic #PancreaticCancer USA: https://t.co/g47pJg3bBF (Threshold of $200,000/QALY gained) UK: https://t.co/5GU7F4e4M5 (Threshold of £30,000/QALY gained) Why is FOLFIRINOX so expensive in US? Also who use
#HealthEconJA Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer https://t.co/w63AmFjj62